IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

News

Researchers at IRB Barcelona have identified these genetic footprints produced by some cancer treatments and have for the first time been able to calculate the genetic toxicity of some of these treatments. Claudia Arnedo, IRB Barcelona.
Scientific - Nature Genetics
Genetic alterations caused by cancer therapies identified
José Picón (Fundación Tatiana Pérez de Guzmán el Bueno-FTPGB), Ángel Carracedo, César Nombela (Fúndación Carmen y Severo Ochoa-FCSO), Salvador Aznar (IRB Barcelona), Rosa Menéndez (CSIC), César de Haro (FCSO) y Alvaro Matud (FTPGB)
Institutional
Salvador Aznar Benitah receives the “Premio Fundación Carmen y Severo Ochoa 2019”
Fran Supek, head of the Genome Data Science laboratory at IRB Barcelona
Institutional
Fran Supek becomes an EMBO Young Investigator
Roger Gomis, head of the Growth Control and Metastasis Laboratory, IRB Barcelona.
Institutional
Researcher Roger Gomis receives a grant from the Fundación Fero to study metastatic breast cancer
The SMAD2 protein can have two orientations. Green indicates the open configuration that allows DNA binding and red the closed configuration, which is incompatible with such binding. Maria J. Macias, IRB Barcelona.
Scientific - Genes & Development
Scientists decipher the keys underlying the differences between SMAD2 and SMAD3, two almost identical transcription factors but with distinct roles
Toni Gabaldon, head of the Comparative Genomics lab, IRB Barcelona and BSC-CNS.
Community
Who’s the scientist behind the new Comparative Genomics group?
Photos of the presentation ceremony of the awards given by the Fundació La Marató
Institutional
La Marató awards six projects that involve IRB Barcelona
Innovation
IRB Barcelona receives a boost for internationalisation.
Predictive decision trees optimized to decide if a cancer mutation will become visible to the immune system. Rik G.H. Lindeboom, Radboud University.
Scientific - Nature Genetics
Scientists build machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

Media Mentions

Blog

Do you want to be informed?

Visit our blog.

IRB Blog